RESUMO
The onset of puberty, periods and sexual relationships can be difficult for adolescents and parents. Adolescents with disabilities face a wide range of additional challenges (physical, mental, social and intellectual), which may impact the quality of their lives and those of their families and carers. Research on the use of contraception in young women with disabilities is limited, and clinicians have little practical guidance for best practice. This review article aims to summarise and assess the evidence and guidance for the use of contraception in this group, particularly with regard to management of menstrual and cyclical problems. Multidisciplinary teamwork is important for recognising and addressing the concerns of patients and their carers effectively. The legal and ethical considerations are also highlighted here, as this group of adolescents is highly vulnerable to sexual exploitation and abuse.
Assuntos
Anticoncepcionais Femininos , Desogestrel , Rifampina , Adulto , Interações Medicamentosas , Feminino , Humanos , GravidezAssuntos
Infecções por Chlamydia/diagnóstico , Anticoncepção , Serviços de Planejamento Familiar/organização & administração , Programas de Rastreamento/organização & administração , Adolescente , Adulto , Atitude Frente a Saúde , Infecções por Chlamydia/epidemiologia , Infecções por Chlamydia/prevenção & controle , Busca de Comunicante , Surtos de Doenças/prevenção & controle , Serviços de Planejamento Familiar/estatística & dados numéricos , Feminino , Humanos , Programas de Rastreamento/psicologia , Programas de Rastreamento/estatística & dados numéricos , Administração em Saúde Pública , Fatores de Risco , Reino Unido/epidemiologia , Saúde da MulherRESUMO
OBJECTIVE: To describe and evaluate the training and support provided to the first cohort of community pharmacists to supply progestogen-only emergency contraception (POEC) under a Patient Group Direction (PGD) in Lambeth, Southwark and Lewisham, London. DESIGN: The study comprised (a) a systematic analysis of written and oral data from pharmacists before and during training, and at 5 and 13-14 months after launch; (b) analysis of telephone calls to clinical support and (c) analysis of written pharmacy records. SUBJECTS: A total of 20/22 pharmacists in the first training cohort; 6/23 pharmacists who applied but were not accepted were also followed up. RESULTS: A formal course with role-play was a successful training method, and the course also served as a team-building exercise. Subsequent interviews demonstrated that pharmacists had understood the concept of client confidentiality and gained confidence over time in the use of the PGD. The on-call consultants received 152 calls in the first 12 months of the scheme. Over 80% of the calls concerned clinical criteria (notably including 22% that were queries about oral contraceptives). Frequency ranged from one to eight calls per week with 28% made at weekends. In over half (60%) of the calls the pharmacist was subsequently able to make a supply. Queries over client management resulted in several changes in the protocol. The primary expressed concern for all pharmacists at all time points was how clients might 'misuse' or 'abuse' the service, and this remained a concern despite the fact that it also applies to other routes of supply of POEC. However, the PGD cohort was more positive on local benefits than pharmacists who were not selected. CONCLUSIONS: Training and support have enabled this often-underused group of professionals to participate in an extended reproductive health service. Mobile phones are an essential support tool.
Assuntos
Anticoncepcionais Hormonais Pós-Coito/administração & dosagem , Educação Continuada em Farmácia/normas , Tratamento de Emergência/normas , Capacitação em Serviço/normas , Farmácias/normas , Progestinas/administração & dosagem , Estudos de Coortes , Educação Baseada em Competências/normas , Confidencialidade , Feminino , Pesquisa sobre Serviços de Saúde , Humanos , Londres , Medicamentos sem Prescrição , Gravidez , Competência Profissional , Avaliação de Programas e Projetos de SaúdeRESUMO
A 29-year-old woman with an Implanon contraceptive device in situ presented with persistent and prolonged vaginal bleeding. The implant had been inserted 2 years previously; the patient had been happy with it and had been mainly amenorrhoeic with the occasional light period. She was concerned that the implant had broken during a game of 'rough and tumble' with her son in August 2000. Since the trauma to her arm her bleeding pattern had changed, and she began bleeding heavily for 3 weeks every month. The rod was removed and found to be fractured halfway across its width. A new Implanon device was inserted and the bleeding settled.